Concepts (161)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Influenza in Birds | 2 | 2017 | 528 | 0.58 | Why? |
| Birds | 1 | 2017 | 412 | 0.56 | Why? |
| Epidemiological Monitoring | 4 | 2021 | 3493 | 0.47 | Why? |
| Basic Reproduction Number | 4 | 2021 | 2676 | 0.40 | Why? |
| Benzoxazoles | 2 | 2018 | 47 | 0.37 | Why? |
| Amyloid Neuropathies, Familial | 2 | 2018 | 77 | 0.34 | Why? |
| Public Health Surveillance | 1 | 2021 | 3129 | 0.34 | Why? |
| Epidemiologic Methods | 2 | 2017 | 392 | 0.32 | Why? |
| Influenza A virus | 2 | 2017 | 2234 | 0.31 | Why? |
| Influenza, Human | 5 | 2018 | 10779 | 0.30 | Why? |
| Military Personnel | 1 | 2016 | 1097 | 0.30 | Why? |
| Hemorrhagic Fever, Ebola | 4 | 2017 | 1475 | 0.29 | Why? |
| Contact Tracing | 4 | 2021 | 8448 | 0.29 | Why? |
| Ambulatory Care Facilities | 1 | 2016 | 2063 | 0.27 | Why? |
| Immunity, Herd | 2 | 2020 | 1011 | 0.24 | Why? |
| Population Surveillance | 3 | 2021 | 4967 | 0.21 | Why? |
| Hong Kong | 6 | 2021 | 3361 | 0.19 | Why? |
| Cardiomyopathies | 2 | 2018 | 997 | 0.18 | Why? |
| Punishment | 1 | 2018 | 50 | 0.18 | Why? |
| Coyotes | 1 | 2017 | 2 | 0.17 | Why? |
| Geese | 1 | 2017 | 29 | 0.17 | Why? |
| Bayes Theorem | 4 | 2020 | 3237 | 0.17 | Why? |
| Ducks | 1 | 2017 | 120 | 0.16 | Why? |
| Prealbumin | 1 | 2018 | 203 | 0.16 | Why? |
| Quarantine | 5 | 2021 | 18418 | 0.15 | Why? |
| Disease Susceptibility | 2 | 2021 | 4002 | 0.15 | Why? |
| Influenza A Virus, H1N1 Subtype | 3 | 2017 | 2984 | 0.15 | Why? |
| Severe Acute Respiratory Syndrome | 7 | 2016 | 12361 | 0.14 | Why? |
| England | 3 | 2021 | 5116 | 0.14 | Why? |
| Public Health Practice | 1 | 2003 | 945 | 0.14 | Why? |
| Immunoassay | 2 | 2021 | 4485 | 0.14 | Why? |
| Disease Outbreaks | 9 | 2021 | 27595 | 0.14 | Why? |
| Models, Psychological | 1 | 2018 | 383 | 0.13 | Why? |
| Plague | 1 | 2017 | 155 | 0.13 | Why? |
| Air Travel | 1 | 2020 | 585 | 0.13 | Why? |
| Seroepidemiologic Studies | 6 | 2021 | 10017 | 0.13 | Why? |
| Clinical Trials, Phase III as Topic | 1 | 2017 | 782 | 0.12 | Why? |
| Prevalence | 7 | 2021 | 25773 | 0.12 | Why? |
| Epidemics | 4 | 2017 | 6407 | 0.12 | Why? |
| Military Medicine | 1 | 2016 | 211 | 0.12 | Why? |
| Models, Statistical | 4 | 2020 | 5312 | 0.12 | Why? |
| Africa, Western | 3 | 2017 | 363 | 0.11 | Why? |
| Poultry Diseases | 1 | 2017 | 588 | 0.11 | Why? |
| Emergency Service, Hospital | 1 | 2016 | 14232 | 0.11 | Why? |
| Spatio-Temporal Analysis | 1 | 2017 | 1182 | 0.10 | Why? |
| Pandemics | 13 | 2021 | 389249 | 0.10 | Why? |
| Interpersonal Relations | 1 | 2018 | 926 | 0.10 | Why? |
| Demography | 1 | 2017 | 1660 | 0.10 | Why? |
| SARS Virus | 6 | 2016 | 13021 | 0.10 | Why? |
| Social Behavior | 1 | 2018 | 882 | 0.10 | Why? |
| Communicable Diseases, Emerging | 3 | 2017 | 2523 | 0.09 | Why? |
| Age Distribution | 2 | 2017 | 3567 | 0.09 | Why? |
| Commerce | 1 | 2017 | 1109 | 0.09 | Why? |
| Republic of Korea | 1 | 2020 | 5858 | 0.09 | Why? |
| Adolescent | 11 | 2021 | 86841 | 0.09 | Why? |
| Models, Theoretical | 4 | 2021 | 6659 | 0.08 | Why? |
| Humans | 38 | 2021 | 930598 | 0.08 | Why? |
| Age Factors | 4 | 2021 | 21039 | 0.07 | Why? |
| Mobile Applications | 1 | 2021 | 3032 | 0.07 | Why? |
| Adult | 15 | 2021 | 244371 | 0.07 | Why? |
| Coronavirus Infections | 7 | 2020 | 253789 | 0.07 | Why? |
| Probability | 2 | 2009 | 923 | 0.07 | Why? |
| Antibodies, Viral | 6 | 2021 | 51949 | 0.07 | Why? |
| Mathematics | 1 | 2003 | 65 | 0.06 | Why? |
| Child, Preschool | 5 | 2021 | 36283 | 0.06 | Why? |
| Young Adult | 6 | 2021 | 93724 | 0.06 | Why? |
| Child | 8 | 2021 | 70012 | 0.06 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.06 | Why? |
| Communicable Disease Control | 3 | 2021 | 29620 | 0.06 | Why? |
| Incidence | 4 | 2020 | 25622 | 0.06 | Why? |
| Stochastic Processes | 1 | 2003 | 369 | 0.06 | Why? |
| China | 6 | 2020 | 50654 | 0.06 | Why? |
| Forecasting | 1 | 2016 | 4492 | 0.06 | Why? |
| Middle Aged | 12 | 2021 | 270681 | 0.05 | Why? |
| Aged | 11 | 2021 | 215776 | 0.05 | Why? |
| Epidemiologic Measurements | 1 | 2020 | 107 | 0.05 | Why? |
| Cluster Analysis | 2 | 2013 | 3001 | 0.05 | Why? |
| Administration, Oral | 2 | 2018 | 2340 | 0.05 | Why? |
| Models, Biological | 1 | 2018 | 4907 | 0.05 | Why? |
| Male | 13 | 2021 | 367725 | 0.05 | Why? |
| Evaluation Studies as Topic | 1 | 2021 | 391 | 0.05 | Why? |
| Ebolavirus | 2 | 2017 | 834 | 0.05 | Why? |
| Europe | 3 | 2020 | 12702 | 0.05 | Why? |
| Female | 13 | 2021 | 380317 | 0.05 | Why? |
| Disease Management | 1 | 2017 | 6841 | 0.05 | Why? |
| Conditioning, Classical | 1 | 2018 | 12 | 0.05 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.05 | Why? |
| Proof of Concept Study | 1 | 2021 | 696 | 0.05 | Why? |
| Northwest Territories | 1 | 2017 | 1 | 0.04 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2017 | 10649 | 0.04 | Why? |
| Virulence Factors | 1 | 2020 | 338 | 0.04 | Why? |
| Liberia | 1 | 2017 | 108 | 0.04 | Why? |
| Travel Medicine | 1 | 2020 | 335 | 0.04 | Why? |
| Disease Progression | 4 | 2021 | 13580 | 0.04 | Why? |
| Guinea | 1 | 2017 | 228 | 0.04 | Why? |
| Sierra Leone | 1 | 2017 | 267 | 0.04 | Why? |
| Yersinia pestis | 1 | 2017 | 58 | 0.04 | Why? |
| False Positive Reactions | 1 | 2021 | 1338 | 0.04 | Why? |
| Animals | 4 | 2018 | 78931 | 0.04 | Why? |
| Walk Test | 1 | 2018 | 461 | 0.04 | Why? |
| Psychological Theory | 1 | 2018 | 226 | 0.04 | Why? |
| United States | 3 | 2020 | 46150 | 0.03 | Why? |
| False Negative Reactions | 1 | 2021 | 1785 | 0.03 | Why? |
| Time Factors | 2 | 2016 | 31397 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Hospitalization | 6 | 2021 | 54280 | 0.03 | Why? |
| Patient Isolation | 2 | 2004 | 3182 | 0.03 | Why? |
| Respiratory Tract Infections | 1 | 2013 | 6817 | 0.03 | Why? |
| Survival Analysis | 2 | 2018 | 7592 | 0.03 | Why? |
| Mortality | 2 | 2021 | 7132 | 0.03 | Why? |
| Longitudinal Studies | 2 | 2018 | 9893 | 0.03 | Why? |
| Immunoglobulin G | 3 | 2021 | 21571 | 0.03 | Why? |
| Checklist | 1 | 2017 | 714 | 0.03 | Why? |
| Disease Notification | 1 | 2017 | 639 | 0.03 | Why? |
| United Kingdom | 2 | 2021 | 18046 | 0.03 | Why? |
| Rats | 1 | 2018 | 2764 | 0.03 | Why? |
| Minority Groups | 1 | 2021 | 1631 | 0.03 | Why? |
| DNA, Viral | 1 | 2020 | 2521 | 0.02 | Why? |
| Middle East | 1 | 2013 | 1418 | 0.02 | Why? |
| Risk | 1 | 2021 | 5288 | 0.02 | Why? |
| Global Health | 2 | 2021 | 13911 | 0.02 | Why? |
| Seasons | 1 | 2021 | 4071 | 0.02 | Why? |
| Wisconsin | 1 | 2009 | 607 | 0.02 | Why? |
| Double-Blind Method | 1 | 2018 | 5988 | 0.02 | Why? |
| Virus Diseases | 2 | 2020 | 3779 | 0.02 | Why? |
| Disease Reservoirs | 1 | 2016 | 1672 | 0.02 | Why? |
| Survival Rate | 2 | 2016 | 9206 | 0.02 | Why? |
| Databases, Factual | 1 | 2020 | 6248 | 0.02 | Why? |
| Coronavirus | 1 | 2013 | 18339 | 0.02 | Why? |
| World Health Organization | 1 | 2017 | 4213 | 0.02 | Why? |
| Algorithms | 1 | 2021 | 7346 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2020 | 11304 | 0.02 | Why? |
| Aged, 80 and over | 3 | 2020 | 88759 | 0.02 | Why? |
| Infection Control | 2 | 2021 | 23131 | 0.02 | Why? |
| Zoonoses | 1 | 2016 | 3034 | 0.01 | Why? |
| Computer Simulation | 1 | 2017 | 4982 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2020 | 17020 | 0.01 | Why? |
| Cross-Sectional Studies | 2 | 2021 | 53120 | 0.01 | Why? |
| Public Health | 2 | 2017 | 16359 | 0.01 | Why? |
| Disease Transmission, Infectious | 2 | 2020 | 9044 | 0.01 | Why? |
| Risk Assessment | 2 | 2017 | 25439 | 0.01 | Why? |
| Cross Infection | 1 | 2003 | 8675 | 0.01 | Why? |
| Infant | 2 | 2020 | 30274 | 0.01 | Why? |
| Likelihood Functions | 1 | 2003 | 719 | 0.01 | Why? |
| Health Policy | 1 | 2021 | 6242 | 0.01 | Why? |
| Social Isolation | 1 | 2020 | 5932 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2021 | 22971 | 0.01 | Why? |
| Geography | 1 | 2006 | 1801 | 0.01 | Why? |
| Retrospective Studies | 2 | 2021 | 105322 | 0.01 | Why? |
| Infant, Newborn | 1 | 2020 | 23105 | 0.01 | Why? |
| Sex Factors | 1 | 2016 | 11014 | 0.01 | Why? |
| Cohort Studies | 1 | 2021 | 36005 | 0.01 | Why? |
| Quality of Life | 1 | 2018 | 9820 | 0.01 | Why? |
| History, 21st Century | 1 | 2004 | 1849 | 0.01 | Why? |
| Heart Failure | 1 | 2018 | 6638 | 0.01 | Why? |
| New York City | 1 | 2009 | 7432 | 0.01 | Why? |
| Health Personnel | 2 | 2021 | 29646 | 0.01 | Why? |
| Antibody Formation | 1 | 2006 | 4038 | 0.01 | Why? |
| Blood Donors | 1 | 2006 | 2956 | 0.01 | Why? |
| Critical Care | 1 | 2009 | 14081 | 0.00 | Why? |
| Severity of Illness Index | 1 | 2009 | 48226 | 0.00 | Why? |
Riley's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(161)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(231)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_